Vanda Pharmaceuticals (VNDA) Work In Process (2014 - 2017)

Vanda Pharmaceuticals has disclosed Work In Process across 4 years of filings, most recently posting $80000.0 for Q4 2017.

• Work In Process for Q4 2017 came in at $80000.0, up 370.59% year-over-year; the trailing twelve-month figure through Dec 2017 was $80000.0 (up 370.59% YoY), and the FY2017 annual result was $80000.0, up 370.59% from the prior year.
• Work In Process came in at $80000.0 for Q4 2017 at Vanda Pharmaceuticals, up from $63000.0 in the prior quarter.
• In the past five years, Work In Process ranged from a high of $1.8 million in Q2 2015 to a low of $7000.0 in Q2 2014.
• The 4-year median for Work In Process is $71500.0 (2017), against an average of $564833.3.
• Across the five-year window, Work In Process soared 25300.0% in 2015 and jumped 370.59% in 2017, its largest moves.
• Vanda Pharmaceuticals' Work In Process stood at $1.3 million in 2014, then gained by 19.0% to $1.6 million in 2015, then slumped by 98.92% to $17000.0 in 2016, then surged by 370.59% to $80000.0 in 2017.
• The last three Work In Process figures came in at $80000.0 (Q4 2017), $63000.0 (Q3 2017), and $131000.0 (Q2 2017), per Business Quant data.